The Cancer News

Zuma 7 trial shows statistically significant overall survival benefit for yescarta

By Editorial Team

By Dr. Luke Fletcher [Willamette Valley Cancer Institute & Research Center](https://www.oregoncancer.com/) _The Zuma 7 trial is a randomized, open-label multicenter study for patients with primary ref...

2022 Updates in Lung Cancer Treatment

By Editorial Team

2023 Summit on Cancer Health Disparities (SCHD)

By Editorial Team

AGILE trial—Ivosidenib plus Azacitidine versus Azacitidine in IDH1 Mutated Acute Myeloid Leukemia

By Binaytara Team

Dr. Aditi Sharma of [Barbara Ann Karmanos Cancer Institute](https://www.karmanos.org/karmanos/karmanos-home) & Dr. Abhishek Mangaonkar of [Mayo Clinic](https://www.mayoclinic.org/)   In the phase III ...

Announcing Binaytara's 2023 Summit on Cancer Health Disparities (SCHD23)

By Editorial Team

The conference will be held at the Grand Hyatt in Seattle on April 28-30, 2023 ------------------------------------------------------------------------------ We invite you to attend the 2023 Summit o...

Volunteer Spotlight: June Zhu

By The Cancer News Team

Zhu Shares About Her Experience Volunteering at Binaytara

Binaytara Foundation Announces Dr. Umang Swami as Editor-in-Chief of the International Journal of Cancer Care & Delivery (IJCCD)

By Editorial Team

Swami Envisions the IJCCD as a Leading Journal in Cancer Health Disparities --------------------------------------------------------------------------- The Binaytara Foundation has named Dr. Umang Sw...

A recap from our 2nd Annual Charity Gala Dinner

By Editorial Team

Binaytara’s Second Annual Gala Dinner was held on July 24, 2021, at the Crowne-Plaza Downtown Seattle and over 100 guests came out to support the organization’s efforts to eliminate global cancer care...

What's going on with brain cancer?

By Editorial Team

Although brain cancer is one of the [rarest](https://www.cancer.net/cancer-types/brain-tumor/statistics) cancers, with a likelihood that it will develop during one’s lifetime being 1%, it is also one ...

Welcoming Dr. Aparna Parikh to our board of directors

By Editorial Team

[Dr. Aparna Parikh](https://www.massgeneral.org/cancer-center/doctors/19980/Aparna-Parikh), an assistant professor of medicine at Harvard University and medical-oncologist at Massachusetts General Hos...